Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Longitudinal kidney function outcome in aging testicular cancer survivors.

Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD.

Acta Oncol. 2020 Apr;59(4):467-474. doi: 10.1080/0284186X.2020.1724328. Epub 2020 Feb 11.

PMID:
32043400
2.

Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors.

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N.

Clin Biochem. 2018 Feb;52:73-79. doi: 10.1016/j.clinbiochem.2017.11.016. Epub 2017 Dec 2.

3.

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.

Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH.

Radiat Oncol. 2006 Aug 3;1:25.

4.

DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.

Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y.

Anticancer Res. 2006 May-Jun;26(3A):1909-16.

5.

Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.

Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH.

Mol Cancer Ther. 2005 Aug;4(8):1231-8.

6.
7.

Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.

Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø.

Oncogene. 2003 Dec 4;22(55):8952-5.

PMID:
14654792

Supplemental Content

Support Center